
Communications consultant and former @WSJ medical tech reporter; Principal at Synthesis Media LLC @media_synthesis
San Francisco
Joined June 2009
- Tweets1.7K
- Following4.2K
- Followers1.3K
- Likes2.2K
Alessa Therapeutics Receives Positive FDA Feedback Following Type C Meeting on Enolen’s Pivotal Phase 3 Trial Design firstwordpharma.com/story/76… via @fwpharma
Alessa Therapeutics Appoints Dr. Peter Carroll and Dr. Neal Shore to Lead Clinical Advisory Board natlawreview.com/press-relea…
Alessa Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference einpresswire.com/article/881… via @ein_news
Tim Hay retweeted
Opinion: Building digital infrastructure isn’t enough — financial inclusion requires better data sharing. India’s Account Aggregator framework offers a blueprint for a secure, consent-driven way to onboard 1.3 billion people into the financial system. devex.com/news/india-s-data-…
Six ways to reach people shut out from formal financial systems context.news/socioeconomic-i…
Bioxytech Retina Announces Strategic Investment from Topcon Healthcare apnews.com/press-release/ein…
Tim Hay retweeted
Health Plans Can Reduce Costs with a Focus on Rising Risk medcitynews.com/2025/04/heal…
Alessa Therapeutics Announces Closing $15M Seed Financing einpresswire.com/article/768… via @ein_news
Tim Hay retweeted
It's official! Our Santo Domingo office is open. 🇩🇴 Find out more about how this important move will help foster economic development and prosperity across the region. dfc.gov/media/press-releases…
Tim Hay retweeted
Can the gig economy be good?
Rahil Rangwala @rahil_r at @AccionVLab offers solutions to some of the gig economy’s pain points for #workers: “Companies should make the informal economy less grueling for the workers around the world who depend on it.”
ssir.org/articles/entry/gig-…
Tim Hay retweeted
BasiGo’s Impressive Progress With Electric Buses In Kenya Illustrates The Incredible Opportunity To Tackle Africa’s Transport Challenges
cleantechnica.com/2024/07/23…
F.L.Putnam Adds 3 Firms Totaling $1.25B in Managed Assets wealthmanagement.com/ria-new…
Lhoopa raises $80M to spur more affordable housing in the Philippines techcrunch.com/2024/07/15/lh… via @techcrunch
Tim Hay retweeted
Apeiron exits through M&A, as @Ligand_LGND gains Qarziba royalties bioworld.com/articles/710465 #biotech #pharma @invIOs_com
Tim Hay retweeted
What's in store for the Bay Area economy? @CNBC's @dee_bosa interviews @MaryDalyEcon June 24th @ 11am PDT: sfpressclub.org/2024/06/13/e…
Tim Hay retweeted
Nonprofit lender Accion Opportunity Fund invested $628 million in the most overlooked, overcharged entrepreneurs across California, Texas, Georgia, New York and Florida.
Here’s what it found:
This Post is from an account that no longer exists. Learn more
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™ | NASDAQ nasdaq.com/press-release/lig…
Tim Hay retweeted
BioCentury's latest roundup of management moves: Agresta joins OnKure as CMO. Plus: Viridian hires Tousignant and an update from Ligand $VRDN $LGND buff.ly/3wh3iYx
Explainable AI lessons from the developers of the EarliPoint Evaluation for autism medicaldesignandoutsourcing.…








